SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-019036
Filing Date
2023-11-14
Accepted
2023-11-14 16:26:03
Documents
67
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q armp-20230930x10q.htm   iXBRL 10-Q 1435615
2 EX-31.1 armp-20230930xex31d1.htm EX-31.1 15793
3 EX-31.2 armp-20230930xex31d2.htm EX-31.2 15275
4 EX-32.1 armp-20230930xex32d1.htm EX-32.1 8042
5 EX-32.2 armp-20230930xex32d2.htm EX-32.2 8215
6 GRAPHIC armp-20230930x10q002.jpg GRAPHIC 45517
  Complete submission text file 0001558370-23-019036.txt   5621579

Data Files

Seq Description Document Type Size
7 EX-101.SCH armp-20230930.xsd EX-101.SCH 43436
8 EX-101.CAL armp-20230930_cal.xml EX-101.CAL 40358
9 EX-101.DEF armp-20230930_def.xml EX-101.DEF 167392
10 EX-101.LAB armp-20230930_lab.xml EX-101.LAB 374611
11 EX-101.PRE armp-20230930_pre.xml EX-101.PRE 289344
61 EXTRACTED XBRL INSTANCE DOCUMENT armp-20230930x10q_htm.xml XML 809966
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 231406839
SIC: 2836 Biological Products, (No Diagnostic Substances)